nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimetrexate—DHFR—Nucleotide Metabolism—POLG—epilepsy syndrome	0.0556	0.243	CbGpPWpGaD
Trimetrexate—DHFR—Niclosamide—Clonazepam—epilepsy syndrome	0.0171	1	CbGdCrCtD
Trimetrexate—DHFR—Nucleotide Metabolism—ADSL—epilepsy syndrome	0.0168	0.0733	CbGpPWpGaD
Trimetrexate—DHFR—One Carbon Metabolism—ATIC—epilepsy syndrome	0.0162	0.0709	CbGpPWpGaD
Trimetrexate—DHFR—Fluoropyrimidine Activity—UPB1—epilepsy syndrome	0.0142	0.0622	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—FOLR1—epilepsy syndrome	0.0132	0.0578	CbGpPWpGaD
Trimetrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PDXK—epilepsy syndrome	0.00946	0.0413	CbGpPWpGaD
Trimetrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PNPO—epilepsy syndrome	0.00865	0.0378	CbGpPWpGaD
Trimetrexate—DHFR—Fluoropyrimidine Activity—ABCG2—epilepsy syndrome	0.00695	0.0304	CbGpPWpGaD
Trimetrexate—DHFR—Fluoropyrimidine Activity—SMUG1—epilepsy syndrome	0.00532	0.0232	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—PLAT—epilepsy syndrome	0.00331	0.0145	CbGpPWpGaD
Trimetrexate—DHFR—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—AKT1—epilepsy syndrome	0.00268	0.0117	CbGpPWpGaD
Trimetrexate—Blood creatinine increased—Pregabalin—epilepsy syndrome	0.00257	0.00343	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—CAT—epilepsy syndrome	0.00256	0.0112	CbGpPWpGaD
Trimetrexate—Anaemia—Diazepam—epilepsy syndrome	0.00254	0.00339	CcSEcCtD
Trimetrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—epilepsy syndrome	0.00253	0.0111	CbGpPWpGaD
Trimetrexate—Confusional state—Propofol—epilepsy syndrome	0.00253	0.00337	CcSEcCtD
Trimetrexate—Hyponatraemia—Gabapentin—epilepsy syndrome	0.00253	0.00337	CcSEcCtD
Trimetrexate—Feeling abnormal—Clobazam—epilepsy syndrome	0.0025	0.00333	CcSEcCtD
Trimetrexate—Convulsion—Fosphenytoin—epilepsy syndrome	0.00249	0.00331	CcSEcCtD
Trimetrexate—Confusional state—Midazolam—epilepsy syndrome	0.00248	0.0033	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Pregabalin—epilepsy syndrome	0.00247	0.00329	CcSEcCtD
Trimetrexate—Body temperature increased—Lacosamide—epilepsy syndrome	0.00247	0.00329	CcSEcCtD
Trimetrexate—Anaemia—Felbamate—epilepsy syndrome	0.00246	0.00328	CcSEcCtD
Trimetrexate—Neutropenia—Valproic Acid—epilepsy syndrome	0.00246	0.00327	CcSEcCtD
Trimetrexate—Confusional state—Levetiracetam—epilepsy syndrome	0.00245	0.00326	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Topiramate—epilepsy syndrome	0.00244	0.00324	CcSEcCtD
Trimetrexate—Vomiting—Trimethadione—epilepsy syndrome	0.00243	0.00324	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Pregabalin—epilepsy syndrome	0.00242	0.00323	CcSEcCtD
Trimetrexate—Convulsion—Vigabatrin—epilepsy syndrome	0.00242	0.00322	CcSEcCtD
Trimetrexate—Rash—Trimethadione—epilepsy syndrome	0.00241	0.00321	CcSEcCtD
Trimetrexate—Dermatitis—Trimethadione—epilepsy syndrome	0.00241	0.00321	CcSEcCtD
Trimetrexate—Anaemia—Zonisamide—epilepsy syndrome	0.00241	0.00321	CcSEcCtD
Trimetrexate—Body temperature increased—Clobazam—epilepsy syndrome	0.0024	0.00319	CcSEcCtD
Trimetrexate—Asthenia—Rufinamide—epilepsy syndrome	0.00239	0.00318	CcSEcCtD
Trimetrexate—Thrombocytopenia—Levetiracetam—epilepsy syndrome	0.00237	0.00316	CcSEcCtD
Trimetrexate—Confusional state—Fosphenytoin—epilepsy syndrome	0.00236	0.00314	CcSEcCtD
Trimetrexate—Blood creatinine increased—Gabapentin—epilepsy syndrome	0.00236	0.00314	CcSEcCtD
Trimetrexate—Pruritus—Rufinamide—epilepsy syndrome	0.00235	0.00313	CcSEcCtD
Trimetrexate—Fatigue—Acetazolamide—epilepsy syndrome	0.00233	0.0031	CcSEcCtD
Trimetrexate—DHFR—E2F transcription factor network—SIRT1—epilepsy syndrome	0.00233	0.0102	CbGpPWpGaD
Trimetrexate—Anaemia—Clonazepam—epilepsy syndrome	0.00232	0.00309	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—GPX1—epilepsy syndrome	0.00232	0.0101	CbGpPWpGaD
Trimetrexate—Anaemia—Phenytoin—epilepsy syndrome	0.00231	0.00307	CcSEcCtD
Trimetrexate—Confusional state—Vigabatrin—epilepsy syndrome	0.0023	0.00306	CcSEcCtD
Trimetrexate—Thrombocytopenia—Fosphenytoin—epilepsy syndrome	0.00229	0.00305	CcSEcCtD
Trimetrexate—Nausea—Trimethadione—epilepsy syndrome	0.00227	0.00303	CcSEcCtD
Trimetrexate—Confusional state—Diazepam—epilepsy syndrome	0.00226	0.00302	CcSEcCtD
Trimetrexate—Convulsion—Zonisamide—epilepsy syndrome	0.00226	0.00301	CcSEcCtD
Trimetrexate—Asthenia—Lacosamide—epilepsy syndrome	0.00224	0.00298	CcSEcCtD
Trimetrexate—Feeling abnormal—Acetazolamide—epilepsy syndrome	0.00223	0.00297	CcSEcCtD
Trimetrexate—Neutropenia—Pregabalin—epilepsy syndrome	0.00222	0.00296	CcSEcCtD
Trimetrexate—Pruritus—Lacosamide—epilepsy syndrome	0.00221	0.00294	CcSEcCtD
Trimetrexate—Anaemia—Carbamazepine—epilepsy syndrome	0.0022	0.00293	CcSEcCtD
Trimetrexate—Thrombocytopenia—Diazepam—epilepsy syndrome	0.0022	0.00293	CcSEcCtD
Trimetrexate—Confusional state—Felbamate—epilepsy syndrome	0.00219	0.00292	CcSEcCtD
Trimetrexate—Asthenia—Clobazam—epilepsy syndrome	0.00218	0.0029	CcSEcCtD
Trimetrexate—Fatigue—Propofol—epilepsy syndrome	0.00216	0.00288	CcSEcCtD
Trimetrexate—Convulsion—Phenytoin—epilepsy syndrome	0.00216	0.00288	CcSEcCtD
Trimetrexate—Vomiting—Phenobarbital—epilepsy syndrome	0.00216	0.00287	CcSEcCtD
Trimetrexate—Convulsion—Oxcarbazepine—epilepsy syndrome	0.00215	0.00286	CcSEcCtD
Trimetrexate—Confusional state—Zonisamide—epilepsy syndrome	0.00215	0.00286	CcSEcCtD
Trimetrexate—Pruritus—Clobazam—epilepsy syndrome	0.00215	0.00286	CcSEcCtD
Trimetrexate—Rash—Phenobarbital—epilepsy syndrome	0.00214	0.00285	CcSEcCtD
Trimetrexate—Body temperature increased—Acetazolamide—epilepsy syndrome	0.00214	0.00284	CcSEcCtD
Trimetrexate—Dermatitis—Phenobarbital—epilepsy syndrome	0.00214	0.00284	CcSEcCtD
Trimetrexate—Thrombocytopenia—Felbamate—epilepsy syndrome	0.00213	0.00283	CcSEcCtD
Trimetrexate—Anaemia—Lamotrigine—epilepsy syndrome	0.00213	0.00283	CcSEcCtD
Trimetrexate—Hyponatraemia—Topiramate—epilepsy syndrome	0.00213	0.00283	CcSEcCtD
Trimetrexate—Fatigue—Midazolam—epilepsy syndrome	0.00212	0.00282	CcSEcCtD
Trimetrexate—Vomiting—Rufinamide—epilepsy syndrome	0.00212	0.00282	CcSEcCtD
Trimetrexate—Rash—Rufinamide—epilepsy syndrome	0.0021	0.00279	CcSEcCtD
Trimetrexate—Dermatitis—Rufinamide—epilepsy syndrome	0.0021	0.00279	CcSEcCtD
Trimetrexate—Fatigue—Levetiracetam—epilepsy syndrome	0.00209	0.00278	CcSEcCtD
Trimetrexate—Thrombocytopenia—Zonisamide—epilepsy syndrome	0.00208	0.00277	CcSEcCtD
Trimetrexate—Feeling abnormal—Propofol—epilepsy syndrome	0.00207	0.00275	CcSEcCtD
Trimetrexate—Confusional state—Clonazepam—epilepsy syndrome	0.00207	0.00275	CcSEcCtD
Trimetrexate—Convulsion—Carbamazepine—epilepsy syndrome	0.00206	0.00275	CcSEcCtD
Trimetrexate—Confusional state—Phenytoin—epilepsy syndrome	0.00205	0.00273	CcSEcCtD
Trimetrexate—Confusional state—Oxcarbazepine—epilepsy syndrome	0.00204	0.00272	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—CRP—epilepsy syndrome	0.00203	0.00888	CbGpPWpGaD
Trimetrexate—Feeling abnormal—Midazolam—epilepsy syndrome	0.00202	0.00269	CcSEcCtD
Trimetrexate—Nausea—Phenobarbital—epilepsy syndrome	0.00201	0.00268	CcSEcCtD
Trimetrexate—Thrombocytopenia—Clonazepam—epilepsy syndrome	0.00201	0.00267	CcSEcCtD
Trimetrexate—Feeling abnormal—Levetiracetam—epilepsy syndrome	0.002	0.00266	CcSEcCtD
Trimetrexate—Convulsion—Lamotrigine—epilepsy syndrome	0.002	0.00266	CcSEcCtD
Trimetrexate—Thrombocytopenia—Phenytoin—epilepsy syndrome	0.00199	0.00266	CcSEcCtD
Trimetrexate—Vomiting—Lacosamide—epilepsy syndrome	0.00199	0.00264	CcSEcCtD
Trimetrexate—Blood creatinine increased—Topiramate—epilepsy syndrome	0.00199	0.00264	CcSEcCtD
Trimetrexate—Body temperature increased—Propofol—epilepsy syndrome	0.00198	0.00264	CcSEcCtD
Trimetrexate—Thrombocytopenia—Oxcarbazepine—epilepsy syndrome	0.00198	0.00264	CcSEcCtD
Trimetrexate—Nausea—Rufinamide—epilepsy syndrome	0.00198	0.00263	CcSEcCtD
Trimetrexate—Rash—Lacosamide—epilepsy syndrome	0.00197	0.00262	CcSEcCtD
Trimetrexate—Dermatitis—Lacosamide—epilepsy syndrome	0.00197	0.00262	CcSEcCtD
Trimetrexate—Fatigue—Vigabatrin—epilepsy syndrome	0.00197	0.00262	CcSEcCtD
Trimetrexate—Confusional state—Carbamazepine—epilepsy syndrome	0.00196	0.00261	CcSEcCtD
Trimetrexate—Asthenia—Acetazolamide—epilepsy syndrome	0.00194	0.00258	CcSEcCtD
Trimetrexate—Fatigue—Diazepam—epilepsy syndrome	0.00194	0.00258	CcSEcCtD
Trimetrexate—Feeling abnormal—Fosphenytoin—epilepsy syndrome	0.00193	0.00257	CcSEcCtD
Trimetrexate—Vomiting—Clobazam—epilepsy syndrome	0.00193	0.00257	CcSEcCtD
Trimetrexate—Body temperature increased—Levetiracetam—epilepsy syndrome	0.00192	0.00255	CcSEcCtD
Trimetrexate—Rash—Clobazam—epilepsy syndrome	0.00191	0.00255	CcSEcCtD
Trimetrexate—Dermatitis—Clobazam—epilepsy syndrome	0.00191	0.00254	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Topiramate—epilepsy syndrome	0.00191	0.00254	CcSEcCtD
Trimetrexate—Thrombocytopenia—Carbamazepine—epilepsy syndrome	0.0019	0.00254	CcSEcCtD
Trimetrexate—Confusional state—Lamotrigine—epilepsy syndrome	0.0019	0.00252	CcSEcCtD
Trimetrexate—Feeling abnormal—Vigabatrin—epilepsy syndrome	0.00188	0.0025	CcSEcCtD
Trimetrexate—Fatigue—Felbamate—epilepsy syndrome	0.00187	0.0025	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Topiramate—epilepsy syndrome	0.00187	0.00249	CcSEcCtD
Trimetrexate—DHFR—E2F transcription factor network—PLAU—epilepsy syndrome	0.00186	0.00814	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism of nitric oxide—AKT1—epilepsy syndrome	0.00186	0.00811	CbGpPWpGaD
Trimetrexate—Nausea—Lacosamide—epilepsy syndrome	0.00186	0.00247	CcSEcCtD
Trimetrexate—Feeling abnormal—Diazepam—epilepsy syndrome	0.00185	0.00246	CcSEcCtD
Trimetrexate—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.00185	0.00246	CcSEcCtD
Trimetrexate—Thrombocytopenia—Lamotrigine—epilepsy syndrome	0.00184	0.00245	CcSEcCtD
Trimetrexate—Fatigue—Zonisamide—epilepsy syndrome	0.00183	0.00244	CcSEcCtD
Trimetrexate—Body temperature increased—Vigabatrin—epilepsy syndrome	0.0018	0.0024	CcSEcCtD
Trimetrexate—Nausea—Clobazam—epilepsy syndrome	0.0018	0.0024	CcSEcCtD
Trimetrexate—Asthenia—Propofol—epilepsy syndrome	0.0018	0.0024	CcSEcCtD
Trimetrexate—Feeling abnormal—Felbamate—epilepsy syndrome	0.00179	0.00239	CcSEcCtD
Trimetrexate—Pruritus—Propofol—epilepsy syndrome	0.00178	0.00236	CcSEcCtD
Trimetrexate—DHFR—E2F transcription factor network—ATM—epilepsy syndrome	0.00177	0.00772	CbGpPWpGaD
Trimetrexate—Fatigue—Clonazepam—epilepsy syndrome	0.00177	0.00235	CcSEcCtD
Trimetrexate—Asthenia—Midazolam—epilepsy syndrome	0.00176	0.00235	CcSEcCtD
Trimetrexate—Fatigue—Phenytoin—epilepsy syndrome	0.00176	0.00234	CcSEcCtD
Trimetrexate—Feeling abnormal—Zonisamide—epilepsy syndrome	0.00175	0.00233	CcSEcCtD
Trimetrexate—Fatigue—Oxcarbazepine—epilepsy syndrome	0.00175	0.00233	CcSEcCtD
Trimetrexate—Asthenia—Levetiracetam—epilepsy syndrome	0.00174	0.00232	CcSEcCtD
Trimetrexate—Pruritus—Midazolam—epilepsy syndrome	0.00174	0.00231	CcSEcCtD
Trimetrexate—Body temperature increased—Felbamate—epilepsy syndrome	0.00172	0.00229	CcSEcCtD
Trimetrexate—Vomiting—Acetazolamide—epilepsy syndrome	0.00172	0.00229	CcSEcCtD
Trimetrexate—Pruritus—Levetiracetam—epilepsy syndrome	0.00172	0.00228	CcSEcCtD
Trimetrexate—Neutropenia—Topiramate—epilepsy syndrome	0.00171	0.00228	CcSEcCtD
Trimetrexate—Anaemia—Valproic Acid—epilepsy syndrome	0.00169	0.00225	CcSEcCtD
Trimetrexate—Feeling abnormal—Clonazepam—epilepsy syndrome	0.00169	0.00225	CcSEcCtD
Trimetrexate—Body temperature increased—Zonisamide—epilepsy syndrome	0.00168	0.00224	CcSEcCtD
Trimetrexate—Asthenia—Fosphenytoin—epilepsy syndrome	0.00168	0.00224	CcSEcCtD
Trimetrexate—Feeling abnormal—Phenytoin—epilepsy syndrome	0.00168	0.00224	CcSEcCtD
Trimetrexate—Fatigue—Carbamazepine—epilepsy syndrome	0.00168	0.00223	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—CCL2—epilepsy syndrome	0.00167	0.00731	CbGpPWpGaD
Trimetrexate—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.00167	0.00222	CcSEcCtD
Trimetrexate—Pruritus—Fosphenytoin—epilepsy syndrome	0.00166	0.0022	CcSEcCtD
Trimetrexate—Asthenia—Vigabatrin—epilepsy syndrome	0.00164	0.00218	CcSEcCtD
Trimetrexate—Body temperature increased—Clonazepam—epilepsy syndrome	0.00162	0.00216	CcSEcCtD
Trimetrexate—Fatigue—Lamotrigine—epilepsy syndrome	0.00162	0.00216	CcSEcCtD
Trimetrexate—Pruritus—Vigabatrin—epilepsy syndrome	0.00161	0.00215	CcSEcCtD
Trimetrexate—Asthenia—Diazepam—epilepsy syndrome	0.00161	0.00215	CcSEcCtD
Trimetrexate—Body temperature increased—Phenytoin—epilepsy syndrome	0.00161	0.00214	CcSEcCtD
Trimetrexate—Nausea—Acetazolamide—epilepsy syndrome	0.00161	0.00214	CcSEcCtD
Trimetrexate—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.0016	0.00213	CcSEcCtD
Trimetrexate—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.0016	0.00213	CcSEcCtD
Trimetrexate—Vomiting—Propofol—epilepsy syndrome	0.0016	0.00213	CcSEcCtD
Trimetrexate—Pruritus—Diazepam—epilepsy syndrome	0.00159	0.00212	CcSEcCtD
Trimetrexate—Rash—Propofol—epilepsy syndrome	0.00158	0.00211	CcSEcCtD
Trimetrexate—Dermatitis—Propofol—epilepsy syndrome	0.00158	0.00211	CcSEcCtD
Trimetrexate—Vomiting—Midazolam—epilepsy syndrome	0.00156	0.00208	CcSEcCtD
Trimetrexate—Asthenia—Felbamate—epilepsy syndrome	0.00156	0.00208	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—ALB—epilepsy syndrome	0.00156	0.00681	CbGpPWpGaD
Trimetrexate—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.00155	0.00206	CcSEcCtD
Trimetrexate—Rash—Midazolam—epilepsy syndrome	0.00155	0.00206	CcSEcCtD
Trimetrexate—Dermatitis—Midazolam—epilepsy syndrome	0.00155	0.00206	CcSEcCtD
Trimetrexate—Vomiting—Levetiracetam—epilepsy syndrome	0.00154	0.00205	CcSEcCtD
Trimetrexate—Pruritus—Felbamate—epilepsy syndrome	0.00154	0.00205	CcSEcCtD
Trimetrexate—Body temperature increased—Carbamazepine—epilepsy syndrome	0.00154	0.00205	CcSEcCtD
Trimetrexate—Rash—Levetiracetam—epilepsy syndrome	0.00153	0.00204	CcSEcCtD
Trimetrexate—Anaemia—Pregabalin—epilepsy syndrome	0.00153	0.00204	CcSEcCtD
Trimetrexate—Dermatitis—Levetiracetam—epilepsy syndrome	0.00153	0.00203	CcSEcCtD
Trimetrexate—Asthenia—Zonisamide—epilepsy syndrome	0.00153	0.00203	CcSEcCtD
Trimetrexate—Confusional state—Valproic Acid—epilepsy syndrome	0.00151	0.002	CcSEcCtD
Trimetrexate—Pruritus—Zonisamide—epilepsy syndrome	0.00151	0.002	CcSEcCtD
Trimetrexate—Nausea—Propofol—epilepsy syndrome	0.00149	0.00199	CcSEcCtD
Trimetrexate—Vomiting—Fosphenytoin—epilepsy syndrome	0.00149	0.00198	CcSEcCtD
Trimetrexate—Body temperature increased—Lamotrigine—epilepsy syndrome	0.00149	0.00198	CcSEcCtD
Trimetrexate—Rash—Fosphenytoin—epilepsy syndrome	0.00148	0.00197	CcSEcCtD
Trimetrexate—Dermatitis—Fosphenytoin—epilepsy syndrome	0.00147	0.00196	CcSEcCtD
Trimetrexate—Asthenia—Clonazepam—epilepsy syndrome	0.00147	0.00196	CcSEcCtD
Trimetrexate—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.00146	0.00195	CcSEcCtD
Trimetrexate—Asthenia—Phenytoin—epilepsy syndrome	0.00146	0.00195	CcSEcCtD
Trimetrexate—Nausea—Midazolam—epilepsy syndrome	0.00146	0.00194	CcSEcCtD
Trimetrexate—Asthenia—Oxcarbazepine—epilepsy syndrome	0.00145	0.00194	CcSEcCtD
Trimetrexate—Pruritus—Clonazepam—epilepsy syndrome	0.00145	0.00193	CcSEcCtD
Trimetrexate—Vomiting—Vigabatrin—epilepsy syndrome	0.00145	0.00193	CcSEcCtD
Trimetrexate—Pruritus—Phenytoin—epilepsy syndrome	0.00144	0.00192	CcSEcCtD
Trimetrexate—Nausea—Levetiracetam—epilepsy syndrome	0.00144	0.00192	CcSEcCtD
Trimetrexate—Rash—Vigabatrin—epilepsy syndrome	0.00144	0.00192	CcSEcCtD
Trimetrexate—Dermatitis—Vigabatrin—epilepsy syndrome	0.00144	0.00191	CcSEcCtD
Trimetrexate—Pruritus—Oxcarbazepine—epilepsy syndrome	0.00143	0.00191	CcSEcCtD
Trimetrexate—Convulsion—Pregabalin—epilepsy syndrome	0.00143	0.00191	CcSEcCtD
Trimetrexate—Vomiting—Diazepam—epilepsy syndrome	0.00143	0.0019	CcSEcCtD
Trimetrexate—Rash—Diazepam—epilepsy syndrome	0.00142	0.00189	CcSEcCtD
Trimetrexate—Dermatitis—Diazepam—epilepsy syndrome	0.00142	0.00188	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—RELA—epilepsy syndrome	0.0014	0.00613	CbGpPWpGaD
Trimetrexate—Anaemia—Gabapentin—epilepsy syndrome	0.0014	0.00187	CcSEcCtD
Trimetrexate—Asthenia—Carbamazepine—epilepsy syndrome	0.0014	0.00186	CcSEcCtD
Trimetrexate—Nausea—Fosphenytoin—epilepsy syndrome	0.00139	0.00185	CcSEcCtD
Trimetrexate—Vomiting—Felbamate—epilepsy syndrome	0.00138	0.00184	CcSEcCtD
Trimetrexate—Pruritus—Carbamazepine—epilepsy syndrome	0.00138	0.00183	CcSEcCtD
Trimetrexate—Rash—Felbamate—epilepsy syndrome	0.00137	0.00183	CcSEcCtD
Trimetrexate—Dermatitis—Felbamate—epilepsy syndrome	0.00137	0.00182	CcSEcCtD
Trimetrexate—Confusional state—Pregabalin—epilepsy syndrome	0.00136	0.00181	CcSEcCtD
Trimetrexate—Nausea—Vigabatrin—epilepsy syndrome	0.00136	0.0018	CcSEcCtD
Trimetrexate—Vomiting—Zonisamide—epilepsy syndrome	0.00135	0.0018	CcSEcCtD
Trimetrexate—Asthenia—Lamotrigine—epilepsy syndrome	0.00135	0.0018	CcSEcCtD
Trimetrexate—Rash—Zonisamide—epilepsy syndrome	0.00134	0.00179	CcSEcCtD
Trimetrexate—Dermatitis—Zonisamide—epilepsy syndrome	0.00134	0.00178	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—PAFAH1B1—epilepsy syndrome	0.00134	0.00584	CbGpPWpGaD
Trimetrexate—Nausea—Diazepam—epilepsy syndrome	0.00133	0.00178	CcSEcCtD
Trimetrexate—Pruritus—Lamotrigine—epilepsy syndrome	0.00133	0.00177	CcSEcCtD
Trimetrexate—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.00132	0.00176	CcSEcCtD
Trimetrexate—Convulsion—Gabapentin—epilepsy syndrome	0.00131	0.00175	CcSEcCtD
Trimetrexate—Vomiting—Clonazepam—epilepsy syndrome	0.0013	0.00174	CcSEcCtD
Trimetrexate—Vomiting—Phenytoin—epilepsy syndrome	0.0013	0.00172	CcSEcCtD
Trimetrexate—Rash—Clonazepam—epilepsy syndrome	0.00129	0.00172	CcSEcCtD
Trimetrexate—Dermatitis—Clonazepam—epilepsy syndrome	0.00129	0.00172	CcSEcCtD
Trimetrexate—Nausea—Felbamate—epilepsy syndrome	0.00129	0.00172	CcSEcCtD
Trimetrexate—Vomiting—Oxcarbazepine—epilepsy syndrome	0.00129	0.00172	CcSEcCtD
Trimetrexate—Fatigue—Valproic Acid—epilepsy syndrome	0.00129	0.00171	CcSEcCtD
Trimetrexate—Rash—Phenytoin—epilepsy syndrome	0.00128	0.00171	CcSEcCtD
Trimetrexate—Dermatitis—Phenytoin—epilepsy syndrome	0.00128	0.00171	CcSEcCtD
Trimetrexate—Rash—Oxcarbazepine—epilepsy syndrome	0.00128	0.0017	CcSEcCtD
Trimetrexate—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.00128	0.0017	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—IL1B—epilepsy syndrome	0.00127	0.00554	CbGpPWpGaD
Trimetrexate—Nausea—Zonisamide—epilepsy syndrome	0.00126	0.00168	CcSEcCtD
Trimetrexate—Confusional state—Gabapentin—epilepsy syndrome	0.00125	0.00166	CcSEcCtD
Trimetrexate—DHFR—Metabolism—CA13—epilepsy syndrome	0.00124	0.0054	CbGpPWpGaD
Trimetrexate—Vomiting—Carbamazepine—epilepsy syndrome	0.00124	0.00165	CcSEcCtD
Trimetrexate—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.00123	0.00164	CcSEcCtD
Trimetrexate—Rash—Carbamazepine—epilepsy syndrome	0.00123	0.00163	CcSEcCtD
Trimetrexate—Dermatitis—Carbamazepine—epilepsy syndrome	0.00123	0.00163	CcSEcCtD
Trimetrexate—Nausea—Clonazepam—epilepsy syndrome	0.00122	0.00162	CcSEcCtD
Trimetrexate—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.00121	0.00161	CcSEcCtD
Trimetrexate—Nausea—Phenytoin—epilepsy syndrome	0.00121	0.00161	CcSEcCtD
Trimetrexate—Nausea—Oxcarbazepine—epilepsy syndrome	0.0012	0.0016	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—PAFAH1B1—epilepsy syndrome	0.0012	0.00522	CbGpPWpGaD
Trimetrexate—Vomiting—Lamotrigine—epilepsy syndrome	0.00119	0.00159	CcSEcCtD
Trimetrexate—Rash—Lamotrigine—epilepsy syndrome	0.00119	0.00158	CcSEcCtD
Trimetrexate—Dermatitis—Lamotrigine—epilepsy syndrome	0.00118	0.00158	CcSEcCtD
Trimetrexate—Body temperature increased—Valproic Acid—epilepsy syndrome	0.00118	0.00157	CcSEcCtD
Trimetrexate—Anaemia—Topiramate—epilepsy syndrome	0.00118	0.00157	CcSEcCtD
Trimetrexate—Fatigue—Pregabalin—epilepsy syndrome	0.00116	0.00155	CcSEcCtD
Trimetrexate—Nausea—Carbamazepine—epilepsy syndrome	0.00116	0.00154	CcSEcCtD
Trimetrexate—DHFR—Disease—PDXK—epilepsy syndrome	0.00112	0.00489	CbGpPWpGaD
Trimetrexate—Nausea—Lamotrigine—epilepsy syndrome	0.00112	0.00149	CcSEcCtD
Trimetrexate—Feeling abnormal—Pregabalin—epilepsy syndrome	0.00111	0.00148	CcSEcCtD
Trimetrexate—Convulsion—Topiramate—epilepsy syndrome	0.00111	0.00147	CcSEcCtD
Trimetrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—epilepsy syndrome	0.00109	0.00478	CbGpPWpGaD
Trimetrexate—Asthenia—Valproic Acid—epilepsy syndrome	0.00107	0.00143	CcSEcCtD
Trimetrexate—Fatigue—Gabapentin—epilepsy syndrome	0.00107	0.00142	CcSEcCtD
Trimetrexate—Body temperature increased—Pregabalin—epilepsy syndrome	0.00107	0.00142	CcSEcCtD
Trimetrexate—Pruritus—Valproic Acid—epilepsy syndrome	0.00106	0.00141	CcSEcCtD
Trimetrexate—Confusional state—Topiramate—epilepsy syndrome	0.00105	0.0014	CcSEcCtD
Trimetrexate—DHFR—Disease—PNPO—epilepsy syndrome	0.00102	0.00447	CbGpPWpGaD
Trimetrexate—DHFR—Disease—EPM2A—epilepsy syndrome	0.00102	0.00447	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NHLRC1—epilepsy syndrome	0.00102	0.00447	CbGpPWpGaD
Trimetrexate—Feeling abnormal—Gabapentin—epilepsy syndrome	0.00102	0.00136	CcSEcCtD
Trimetrexate—Thrombocytopenia—Topiramate—epilepsy syndrome	0.00102	0.00136	CcSEcCtD
Trimetrexate—Body temperature increased—Gabapentin—epilepsy syndrome	0.000979	0.0013	CcSEcCtD
Trimetrexate—Asthenia—Pregabalin—epilepsy syndrome	0.000969	0.00129	CcSEcCtD
Trimetrexate—Pruritus—Pregabalin—epilepsy syndrome	0.000955	0.00127	CcSEcCtD
Trimetrexate—DHFR—Disease—SV2A—epilepsy syndrome	0.000952	0.00416	CbGpPWpGaD
Trimetrexate—Vomiting—Valproic Acid—epilepsy syndrome	0.00095	0.00126	CcSEcCtD
Trimetrexate—Rash—Valproic Acid—epilepsy syndrome	0.000942	0.00125	CcSEcCtD
Trimetrexate—Dermatitis—Valproic Acid—epilepsy syndrome	0.000941	0.00125	CcSEcCtD
Trimetrexate—DHFR—Metabolism—PDXK—epilepsy syndrome	0.000938	0.0041	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ADK—epilepsy syndrome	0.000938	0.0041	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—L2HGDH—epilepsy syndrome	0.000938	0.0041	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GLUD1—epilepsy syndrome	0.000938	0.0041	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—FAR1—epilepsy syndrome	0.000938	0.0041	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CERS1—epilepsy syndrome	0.000938	0.0041	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—TNF—epilepsy syndrome	0.000921	0.00402	CbGpPWpGaD
Trimetrexate—Fatigue—Topiramate—epilepsy syndrome	0.000898	0.0012	CcSEcCtD
Trimetrexate—Asthenia—Gabapentin—epilepsy syndrome	0.000888	0.00118	CcSEcCtD
Trimetrexate—Nausea—Valproic Acid—epilepsy syndrome	0.000887	0.00118	CcSEcCtD
Trimetrexate—Pruritus—Gabapentin—epilepsy syndrome	0.000876	0.00117	CcSEcCtD
Trimetrexate—Vomiting—Pregabalin—epilepsy syndrome	0.000858	0.00114	CcSEcCtD
Trimetrexate—Feeling abnormal—Topiramate—epilepsy syndrome	0.000858	0.00114	CcSEcCtD
Trimetrexate—DHFR—Metabolism—GAMT—epilepsy syndrome	0.000858	0.00375	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NHLRC1—epilepsy syndrome	0.000858	0.00375	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—EPM2A—epilepsy syndrome	0.000858	0.00375	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PNPO—epilepsy syndrome	0.000858	0.00375	CbGpPWpGaD
Trimetrexate—Rash—Pregabalin—epilepsy syndrome	0.000851	0.00113	CcSEcCtD
Trimetrexate—Dermatitis—Pregabalin—epilepsy syndrome	0.000851	0.00113	CcSEcCtD
Trimetrexate—DHFR—Disease—PFKL—epilepsy syndrome	0.000849	0.00371	CbGpPWpGaD
Trimetrexate—Body temperature increased—Topiramate—epilepsy syndrome	0.000823	0.0011	CcSEcCtD
Trimetrexate—Nausea—Pregabalin—epilepsy syndrome	0.000802	0.00107	CcSEcCtD
Trimetrexate—DHFR—Metabolism—QDPR—epilepsy syndrome	0.000797	0.00348	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CA4—epilepsy syndrome	0.000797	0.00348	CbGpPWpGaD
Trimetrexate—Vomiting—Gabapentin—epilepsy syndrome	0.000787	0.00105	CcSEcCtD
Trimetrexate—Rash—Gabapentin—epilepsy syndrome	0.000781	0.00104	CcSEcCtD
Trimetrexate—Dermatitis—Gabapentin—epilepsy syndrome	0.00078	0.00104	CcSEcCtD
Trimetrexate—DHFR—Disease—STX1B—epilepsy syndrome	0.000776	0.00339	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—COX3—epilepsy syndrome	0.00075	0.00327	CbGpPWpGaD
Trimetrexate—Asthenia—Topiramate—epilepsy syndrome	0.000747	0.000995	CcSEcCtD
Trimetrexate—Pruritus—Topiramate—epilepsy syndrome	0.000737	0.000981	CcSEcCtD
Trimetrexate—Nausea—Gabapentin—epilepsy syndrome	0.000735	0.000979	CcSEcCtD
Trimetrexate—DHFR—Disease—PPP1R3C—epilepsy syndrome	0.000722	0.00315	CbGpPWpGaD
Trimetrexate—DHFR—Disease—GBE1—epilepsy syndrome	0.000722	0.00315	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CPSF4—epilepsy syndrome	0.000722	0.00315	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CACNA2D2—epilepsy syndrome	0.000711	0.0031	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—KCNB1—epilepsy syndrome	0.000711	0.0031	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PFKL—epilepsy syndrome	0.000711	0.0031	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—SLCO1A2—epilepsy syndrome	0.000711	0.0031	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—SLC6A8—epilepsy syndrome	0.000711	0.0031	CbGpPWpGaD
Trimetrexate—Vomiting—Topiramate—epilepsy syndrome	0.000662	0.000882	CcSEcCtD
Trimetrexate—Rash—Topiramate—epilepsy syndrome	0.000657	0.000874	CcSEcCtD
Trimetrexate—Dermatitis—Topiramate—epilepsy syndrome	0.000656	0.000874	CcSEcCtD
Trimetrexate—DHFR—Metabolism—NEU1—epilepsy syndrome	0.00065	0.00284	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—UPB1—epilepsy syndrome	0.00065	0.00284	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ATIC—epilepsy syndrome	0.00065	0.00284	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—HSD17B4—epilepsy syndrome	0.000626	0.00273	CbGpPWpGaD
Trimetrexate—Nausea—Topiramate—epilepsy syndrome	0.000619	0.000824	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—APEX1—epilepsy syndrome	0.00061	0.00267	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PPP1R3C—epilepsy syndrome	0.000604	0.00264	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GBE1—epilepsy syndrome	0.000604	0.00264	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ST3GAL3—epilepsy syndrome	0.0006	0.00262	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ASAH1—epilepsy syndrome	0.000568	0.00248	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—STXBP1—epilepsy syndrome	0.000553	0.00241	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—APEX1—epilepsy syndrome	0.000546	0.00238	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ALAD—epilepsy syndrome	0.000539	0.00235	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NT5E—epilepsy syndrome	0.000539	0.00235	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ALDH7A1—epilepsy syndrome	0.000514	0.00224	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CACNA1A—epilepsy syndrome	0.000514	0.00224	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ST3GAL3—epilepsy syndrome	0.000503	0.0022	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ADSL—epilepsy syndrome	0.000493	0.00215	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—H2AFX—epilepsy syndrome	0.000488	0.00213	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GLUL—epilepsy syndrome	0.000483	0.00211	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CACNA1D—epilepsy syndrome	0.000474	0.00207	CbGpPWpGaD
Trimetrexate—DHFR—telencephalon—epilepsy syndrome	0.000464	0.167	CbGeAlD
Trimetrexate—DHFR—Metabolism—TXNRD1—epilepsy syndrome	0.000444	0.00194	CbGpPWpGaD
Trimetrexate—DHFR—Disease—EIF2AK2—epilepsy syndrome	0.000437	0.00191	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—H2AFX—epilepsy syndrome	0.000436	0.00191	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—AQP1—epilepsy syndrome	0.000431	0.00188	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PPIA—epilepsy syndrome	0.000405	0.00177	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CHRM3—epilepsy syndrome	0.000389	0.0017	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—KCNJ11—epilepsy syndrome	0.000389	0.0017	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—PRKCB—epilepsy syndrome	0.000388	0.0017	CbGpPWpGaD
Trimetrexate—DHFR—medulla oblongata—epilepsy syndrome	0.000365	0.131	CbGeAlD
Trimetrexate—DHFR—Cell Cycle—ATM—epilepsy syndrome	0.000355	0.00155	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—PRKCB—epilepsy syndrome	0.000347	0.00152	CbGpPWpGaD
Trimetrexate—DHFR—midbrain—epilepsy syndrome	0.000333	0.12	CbGeAlD
Trimetrexate—DHFR—spinal cord—epilepsy syndrome	0.000325	0.117	CbGeAlD
Trimetrexate—DHFR—Metabolism—ABCG2—epilepsy syndrome	0.000317	0.00139	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CYP2C19—epilepsy syndrome	0.000309	0.00135	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CYP11A1—epilepsy syndrome	0.000307	0.00134	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SLC2A1—epilepsy syndrome	0.0003	0.00131	CbGpPWpGaD
Trimetrexate—DHFR—Disease—JUNB—epilepsy syndrome	0.000297	0.0013	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NOS1—epilepsy syndrome	0.000295	0.00129	CbGpPWpGaD
Trimetrexate—DHFR—head—epilepsy syndrome	0.000289	0.104	CbGeAlD
Trimetrexate—DHFR—Disease—HBEGF—epilepsy syndrome	0.000282	0.00123	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CYP2D6—epilepsy syndrome	0.000277	0.00121	CbGpPWpGaD
Trimetrexate—DHFR—Disease—AKT3—epilepsy syndrome	0.000277	0.00121	CbGpPWpGaD
Trimetrexate—DHFR—nervous system—epilepsy syndrome	0.000274	0.0985	CbGeAlD
Trimetrexate—DHFR—Disease—ADAM10—epilepsy syndrome	0.00027	0.00118	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ADRA2A—epilepsy syndrome	0.000264	0.00115	CbGpPWpGaD
Trimetrexate—DHFR—central nervous system—epilepsy syndrome	0.000264	0.0949	CbGeAlD
Trimetrexate—DHFR—Metabolism—BCHE—epilepsy syndrome	0.000263	0.00115	CbGpPWpGaD
Trimetrexate—DHFR—cerebellum—epilepsy syndrome	0.000258	0.0927	CbGeAlD
Trimetrexate—DHFR—Disease—CDC42—epilepsy syndrome	0.000252	0.0011	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—SLC2A1—epilepsy syndrome	0.000251	0.0011	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PLCB1—epilepsy syndrome	0.000248	0.00108	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—TH—epilepsy syndrome	0.000247	0.00108	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HES1—epilepsy syndrome	0.000231	0.00101	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FYN—epilepsy syndrome	0.000225	0.000981	CbGpPWpGaD
Trimetrexate—DHFR—Disease—H2AFX—epilepsy syndrome	0.000224	0.000977	CbGpPWpGaD
Trimetrexate—DHFR—Disease—YWHAZ—epilepsy syndrome	0.000216	0.000943	CbGpPWpGaD
Trimetrexate—DHFR—brain—epilepsy syndrome	0.00021	0.0753	CbGeAlD
Trimetrexate—DHFR—Disease—CCR5—epilepsy syndrome	0.000208	0.000907	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—HMOX1—epilepsy syndrome	0.000206	0.000901	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CAT—epilepsy syndrome	0.000204	0.000889	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ABCB1—epilepsy syndrome	0.000198	0.000865	CbGpPWpGaD
Trimetrexate—DHFR—Disease—TSC2—epilepsy syndrome	0.000193	0.000843	CbGpPWpGaD
Trimetrexate—DHFR—Disease—APOE—epilepsy syndrome	0.000189	0.000825	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GPX1—epilepsy syndrome	0.000184	0.000804	CbGpPWpGaD
Trimetrexate—DHFR—Disease—IL6ST—epilepsy syndrome	0.000177	0.000775	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NOS2—epilepsy syndrome	0.000176	0.000769	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—AGT—epilepsy syndrome	0.000162	0.000705	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—APOE—epilepsy syndrome	0.000158	0.000691	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FGF2—epilepsy syndrome	0.000144	0.000627	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—POMC—epilepsy syndrome	0.000136	0.000594	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MTOR—epilepsy syndrome	0.000131	0.000571	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PTGS2—epilepsy syndrome	0.000129	0.000565	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ALB—epilepsy syndrome	0.000124	0.000541	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PTGS2—epilepsy syndrome	0.000108	0.000473	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SRC—epilepsy syndrome	0.000105	0.000457	CbGpPWpGaD
Trimetrexate—DHFR—Disease—AKT1—epilepsy syndrome	6.51e-05	0.000284	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—AKT1—epilepsy syndrome	5.45e-05	0.000238	CbGpPWpGaD
